Pat Miles
Chairman and CEO
Replay available
Alphatec Holdings, Inc. (NASDAQ: ATEC) Q1 2025 earnings conference call, held 2025-05-01. Replay captured from the company's public earnings webcast.

Chairman and CEO
CFO
Analyst, Lake Street Capital Markets
Analyst, Wells Fargo
Analyst, Barclays
Analyst, Stifel
Analyst, Jefferies
Analyst, Needham
Analyst, H.C. Wainwright
everyone and welcome to the webcast of ATEC's first quarter financial results we would like to remind everyone that participants on the call will make forward-looking statements these statements are based on current expectations and are subject to uncertainties that could cause actual results to differ materially these uncertainties are detailed in documents filed regularly with the sec during this call you may hear the company refer to non-gap or adjusted measures Reconciliations of these measures to U.S. GAAP can be found in the supplemental financial tables included in today's press release, which identify and quantify all excluded items and provide management's view of why this information is useful to investors. Leading today's call will be ATEX Chairman and CEO Pat Miles and CFO Todd Koenig. Now I will turn the call over to Pat Miles. Thanks much Greg and welcome everybody to the Q1 2025 financial results ATEC earning call. There will be a few forward looking statements which I would ask for you to review at your leisure. So really a great start to 2025. Enjoyed revenue growth at 22% with surgical growth at 24%. That's about four times the market if you're keeping track. This is really a phenomenal result for the largest pure play spine company in ATEC. So Q1 is always a little challenging seasonally when it comes to profitability and cash flow. As cash flow or case volume slows compared to Q4, taxes reset, and we see a disproportionate share of meetings and events. But in spite of all of that, we delivered $11 million of adjusted EBITDA, which is our second best quarter ever. and above expectations. And from a cash flow perspective, our cash burn in Q1 was at the low end of the range at $15 million. So profitability and cash flow performance in Q1 has really p...